68Ga PSMA PET/CT与18F-FDG PET/CT用于检测富马酸水合酶缺乏型肾细胞癌病例中的病变。

IF 0.9 4区医学 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

Hellenic journal of nuclear medicine Pub Date : 2023-05-01 Epub Date: 2023-08-04 DOI:10.1967/s002449912579

Zhibing Qi, Xilan Yao, Minggang Su, Rui Huang

{"title":"68Ga PSMA PET/CT与18F-FDG PET/CT用于检测富马酸水合酶缺乏型肾细胞癌病例中的病变。","authors":"Zhibing Qi, Xilan Yao, Minggang Su, Rui Huang","doi":"10.1967/s002449912579","DOIUrl":null,"url":null,"abstract":"Gallium-68 (68Ga)-prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) and fluorine-18-fluorodeoxyglucose(18F-FDG) PET/CT were performed for staging in a 51-year-old man with renal cell carcinoma. Compared with 18F-FDG PET/CT, no obvious tracer uptake in right renal mass and less metastatic lesions were found on 68Ga-PSMA PET/CT. Postoperative pathology demonstrated the diagnosis of fumarate hydratase-deficient renal cell carcinoma (FHRCC).","PeriodicalId":12871,"journal":{"name":"Hellenic journal of nuclear medicine","volume":"26 2","pages":"155-156"},"PeriodicalIF":0.9000,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"68Ga-PSMA PET/CT versus 18F-FDG PET/CT for detecting lesions in a case of fumarate hydratase-deficient renal cell carcinoma.\",\"authors\":\"Zhibing Qi, Xilan Yao, Minggang Su, Rui Huang\",\"doi\":\"10.1967/s002449912579\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Gallium-68 (68Ga)-prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) and fluorine-18-fluorodeoxyglucose(18F-FDG) PET/CT were performed for staging in a 51-year-old man with renal cell carcinoma. Compared with 18F-FDG PET/CT, no obvious tracer uptake in right renal mass and less metastatic lesions were found on 68Ga-PSMA PET/CT. Postoperative pathology demonstrated the diagnosis of fumarate hydratase-deficient renal cell carcinoma (FHRCC).\",\"PeriodicalId\":12871,\"journal\":{\"name\":\"Hellenic journal of nuclear medicine\",\"volume\":\"26 2\",\"pages\":\"155-156\"},\"PeriodicalIF\":0.9000,\"publicationDate\":\"2023-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Hellenic journal of nuclear medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1967/s002449912579\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/8/4 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hellenic journal of nuclear medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1967/s002449912579","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/8/4 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}

引用次数: 0

摘要

对一名51岁肾细胞癌患者进行了镓-68（68Ga）-前列腺特异性膜抗原（PSMA）正电子发射断层扫描/计算机断层扫描（PET/CT）和氟-18氟脱氧葡萄糖（18F-FDG）PET/CT分期。与18F-FDG PET/CT相比，68Ga-PSMA PET/CT在右肾肿块中未发现明显的示踪剂摄取，转移灶较少。术后病理证实富马酸水合酶缺乏型肾细胞癌（FHRCC）的诊断。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

⁶⁸Ga-PSMA PET/CT versus ¹⁸F-FDG PET/CT for detecting lesions in a case of fumarate hydratase-deficient renal cell carcinoma.

Gallium-68 (⁶⁸Ga)-prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) and fluorine-18-fluorodeoxyglucose(¹⁸F-FDG) PET/CT were performed for staging in a 51-year-old man with renal cell carcinoma. Compared with ¹⁸F-FDG PET/CT, no obvious tracer uptake in right renal mass and less metastatic lesions were found on ⁶⁸Ga-PSMA PET/CT. Postoperative pathology demonstrated the diagnosis of fumarate hydratase-deficient renal cell carcinoma (FHRCC).

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Hellenic journal of nuclear medicine 医学-核医学

CiteScore

1.40

自引率

6.70%

发文量

审稿时长

>12 weeks

期刊介绍： The Hellenic Journal of Nuclear Medicine published by the Hellenic Society of Nuclear Medicine in Thessaloniki, aims to contribute to research, to education and cover the scientific and professional interests of physicians, in the field of nuclear medicine and in medicine in general. The journal may publish papers of nuclear medicine and also papers that refer to related subjects as dosimetry, computer science, targeting of gene expression, radioimmunoassay, radiation protection, biology, cell trafficking, related historical brief reviews and other related subjects. Original papers are preferred. The journal may after special agreement publish supplements covering important subjects, dully reviewed and subscripted separately.